NCT06127160 - Patient-Directed Antimicrobial Duration in Acute Uncomplicated Pyelonephritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 4, 2024

Primary Completion Date

August 29, 2025

Study Completion Date

August 29, 2025

Conditions

Pyelonephritis Acute

Interventions

DRUG

Cephalexin

Cephalexin 1000 mg by mouth 3 times daily for 10 days

DRUG

Cephalexin or placebo

Cephalexin 1000 mg by mouth 3 times daily for a minimum of 3 days, once participant reports symptom resolution for 24 hours they will switch to placebo for remainder of 10 days of treatment.

Trial Locations (2)

52242

University of Iowa Hospitals and Clinics, Iowa City

91342

Olive View - UCLA Medical Center, Sylmar

All Listed Sponsors

collaborator

University of California, Los Angeles

OTHER

lead

Brett A Faine

OTHER